66.06
Ptc Therapeutics Inc (PTCT) 最新ニュース
How PTC Therapeutics Inc. stock compares to growth peersWeekly Trade Review & Fast Moving Stock Trade Plans - newser.com
Using RSI to spot recovery in PTC Therapeutics Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - newser.com
Live market analysis of PTC Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
Relative strength of PTC Therapeutics Inc. in sector analysis - newser.com
Using flow based indicators on PTC Therapeutics Inc.Market Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
PTC Therapeutics, Inc. Hits New 52-Week High of $67.40 - Markets Mojo
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 3,375 Shares of Stock - MarketBeat
PTC Therapeutics' (PTCT) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Chart based analysis of PTC Therapeutics Inc. trendsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Ptc Therapeutics exec. VP Boulding sells $214k in shares By Investing.com - Investing.com Canada
What does recent volatility data suggest for PTC Therapeutics Inc.Weekly Stock Report & Short-Term High Return Ideas - newser.com
Robeco Institutional Asset Management B.V. Buys Shares of 5,733 PTC Therapeutics, Inc. $PTCT - MarketBeat
RBC Raises Price Target on PTC Therapeutics to $70 From $63, Keeps Outperform Rating - MarketScreener
Mark Elliott Boulding Sells 2,266 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Allan Steven Jacobson Sells 12,000 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Insider Sells $3,632,750.00 in Stock - MarketBeat
Allan Jacobson sells PTC Therapeutics shares for $780,000 - Investing.com
Ptc therapeutics exec. VP Boulding sells $1.6m in stock - Investing.com
Emma Reeve, PTC Therapeutics director, sells $1.68m in shares - Investing.com
Duchenne Muscular Dystrophy Market Report 2034: Epidemiology, Pipeline Therapies, and Recent Regulatory Approvals by DelveInsight | Featuring Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, S - Barchart.com
Real time breakdown of PTC Therapeutics Inc. stock performance2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Evaluating PTC Therapeutics Inc. with trendline analysisJuly 2025 Setups & Verified Technical Signals - newser.com
PTC Therapeutics Stock Sees Momentum Amidst Corporate Developments - StocksToTrade
PTC Therapeutics Bolsters Workforce Amid Stock Option Grants - timothysykes.com
Analysts Shine Spotlight on PTCT in Friedreich’s Ataxia Talks - timothysykes.com
Why PTC Therapeutics Inc. (BH3) stock could outperform next yearDollar Strength & Reliable Intraday Trade Alerts - newser.com
Will PTC Therapeutics Inc. (BH3) stock outperform energy sector in 2025 - newser.com
How to build a custom watchlist for PTC Therapeutics Inc.Quarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Will PTC Therapeutics Inc. rebound enough to break evenCEO Change & Weekly Momentum Picks - newser.com
Is PTC Therapeutics Inc. (BH3) stock among top earnings plays2025 Price Momentum & AI Enhanced Trading Signals - newser.com
PTC Therapeutics Announces New Employee Stock Grants Amid Strategic Developments - timothysykes.com
PTCT Sees Strategic Staff Expansion Amidst Recent Developments - timothysykes.com
Will uniQure’s Results Pressure PTC Therapeutics’ (PTCT) Rare Disease Leadership and Revenue Ambitions? - Sahm
Using AI based signals to follow PTC Therapeutics Inc.2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Ptc Therapeutics stock hits 52-week high at 63.33 USD By Investing.com - Investing.com Nigeria
PTC Therapeutics (NASDAQ:PTCT) Hits New 1-Year HighWhat's Next? - MarketBeat
Ptc Therapeutics stock hits 52-week high at 63.33 USD - Investing.com India
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GuruFocus
19,475 Stock Options, 39,060 RSUs: PTC Therapeutics Awards Major Inducement Grants to New Employees - Stock Titan
大文字化:
|
ボリューム (24 時間):